AW
JSPR icon

Avion Wealth’s Jasper Therapeutics JSPR Stock Holding History

Avion Wealth’s Portfolio JSPR Stock Details JSPR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-214
Closed – – 1428
2025
Q4 		$0 Buy
+214
New +$430 ﹤0.01% 1420

Other funds holding JSPR

VCIM
Velan Capital Investment Management Alpharetta, Georgia $160M AUM 517.12% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
ACA
Acorn Capital Advisors New York $352M AUM 299.18% 1-Year Est. Return
KCM
Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
CG
Carlyle Group Washington, District of Columbia $10.6B AUM 11.25% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return
LPC
Lion Point Capital New York $16.7M AUM 119.35% 1-Year Est. Return

Avion Wealth's JSPR Position: Q1 2026 in Review

Avion Wealth sold out of Jasper Therapeutics (JSPR) in Q1 2026, closing a stake of 214 shares.

Avion Wealth first reported a position in JSPR in Q4 2025 and held it in 1 quarter. The position peaked at $0 in Q4 2025. 58 funds tracked by Wall St. Rank hold JSPR as of Q1 2026.

  • Avion Wealth reported no remaining Jasper Therapeutics position as of Q1 2026 after selling out during the quarter.
  • Avion Wealth sold 214 Jasper Therapeutics shares in Q1 2026.
  • Avion Wealth first reported a position in Jasper Therapeutics in Q4 2025 and held it in 1 quarter.
  • Avion Wealth's Jasper Therapeutics position peaked at $0 in Q4 2025.
  • 58 funds tracked by Wall St. Rank held Jasper Therapeutics as of Q1 2026.

Based on Avion Wealth's 13F filing for Q1 2026, filed 1 May 2026.